원료의약품
Roxithromycin (록시트로마이신)
KDMF APIs
Roxithromycin
품목명 (한글) | 록시트로마이신 |
|---|---|
분류 | 항생물질제제 |
CAS No. | 80214-83-1 |
KDMF 등록번호 | 20050831-9-A-2-02(12) |
제조원 | Zhejiang Zhenyuan Pharmaceutical Co. Ltd. |
규격 | EP/In-house |
품목 정보
IUPAC Name | (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-oxacyclotetradecan-2-one |
|---|---|
Synonyms | (9E)-erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime) |
Description | Roxithromycin is a semi-synthethic macrolide antibiotic that is structurally and pharmacologically similar to erythromycin, azithromycin, or clarithromycin . It was shown to be more effective against certain Gram-negative bacteria, particularly Legionella pneumophila . Roxithromycin exerts its antibacterial action by binding to the bacterial ribosome and interfering with bacterial protein synthesis. It is marketed in Australia as a treatment for respiratory tract, urinary and soft tissue infections. |
Certificate of Analysis | If you need more information, please contact us. |
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신드립니다. (02-579-1056 · ace@acebiopharm.com)